ADVERTISEMENT
ADVERTISEMENT
Oncology shifts to combos, precision care
Executives said one of the biggest challenges is understanding why some patients respond to treatment while others do not.
-
1759953093.png)
Staff Reporter - Thu, 30, Apr 2026
- 16:17 EDT
- 55
'The Next Oncology Wave: Where Value Wins and Only the Fittest Survive' Panelists / USAIC
Boston, April 30: The next wave of cancer treatment will depend less on single “blockbuster” drugs and more on precise combinations tailored to individual patients, as scientists confront the growing complexity and adaptability of tumours, industry leaders said at a high-level panel.
At the USA–India Chamber of Commerce’s BioPharma & Healthcare Summit, executives and researchers said the future of oncology lies in integrating biology, data science and new therapeutic modalities to deliver durable responses — and ultimately, longer survival.
This post is for paying subscribers only
SUBSCRIBE NOWLeave A Comment
Related
ADVERTISEMENT
ADVERTISEMENT
E Paper
Video
Comments
Start the conversation
Become a member of New India Abroad to start commenting.
Sign Up Now
Already have an account? Login